Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS

DL Grieco, SM Maggiore, O Roca, E Spinelli… - Intensive care …, 2021 - Springer
The role of non-invasive respiratory support (high-flow nasal oxygen and noninvasive
ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory …

Analgesia and sedation in patients with ARDS

G Chanques, JM Constantin, JW Devlin, EW Ely… - Intensive care …, 2020 - Springer
Abstract Acute Respiratory Distress Syndrome (ARDS) is one of the most demanding
conditions in an Intensive Care Unit (ICU). Management of analgesia and sedation in ARDS …

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

L Evans, A Rhodes, W Alhazzani, M Antonelli… - Critical care …, 2021 - journals.lww.com
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

Predictors of pneumothorax/pneumomediastinum in mechanically ventilated COVID-19 patients

A Belletti, D Palumbo, A Zangrillo, EV Fominskiy… - Journal of cardiothoracic …, 2021 - Elsevier
Objective To determine the incidence, predictors, and outcome of pneumothorax (PNX)/
pneumomediastinum (PMD) in coronavirus disease 2019 (COVID-19) acute respiratory …

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method

P Nasa, E Azoulay, AK Khanna, R Jain, S Gupta… - Critical Care, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) pandemic has caused
unprecedented pressure on healthcare system globally. Lack of high-quality evidence on …

One-year multidisciplinary follow-up of patients with COVID-19 requiring invasive mechanical ventilation

A Zangrillo, A Belletti, D Palumbo, MR Calvi… - … of Cardiothoracic and …, 2022 - Elsevier
Objectives Patients with COVID-19 frequently develop acute respiratory distress syndrome
(ARDS) requiring intensive care unit (ICU) admission. Data on long-term survival of these …

Challenges in ARDS definition, management, and identification of effective personalized therapies

D Battaglini, B Fazzini, PL Silva, FF Cruz, L Ball… - Journal of Clinical …, 2023 - mdpi.com
Over the last decade, the management of acute respiratory distress syndrome (ARDS) has
made considerable progress both regarding supportive and pharmacologic therapies. Lung …

COVID-19 critical illness: a data-driven review

JC Ginestra, OJL Mitchell, GL Anesi… - Annual review of …, 2022 - annualreviews.org
The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges
in critical care medicine, including extreme demand for intensive care unit (ICU) resources …

Myorelaxants in ARDS patients

S Hraiech, T Yoshida, D Annane, A Duggal… - Intensive care …, 2020 - Springer
Neuromuscular blocking agents (NMBAs) inhibit patient-initiated active breath and the risk of
high tidal volumes and consequent high transpulmonary pressure swings, and minimize …

Evidence-based mechanical ventilatory strategies in ARDS

A Liaqat, M Mason, BJ Foster, S Kulkarni… - Journal of clinical …, 2022 - mdpi.com
Acute respiratory distress syndrome (ARDS) remains one of the leading causes of morbidity
and mortality in critically ill patients despite advancements in the field. Mechanical …